Journal article Closed Access

Human Dosimetry of the NMDA Receptor Ligand [11C]GMOM.

van der Aart, Jasper; van der Doef, Thalia F; Horstman, Paul; Huisman, Marc C; Schuit, Robert C; van Lingen, Arthur; Windhorst, Albert D; van Berckel, Bart,NM; Lammerstma, Adriaan A


Dublin Core Export

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>van der Aart, Jasper</dc:creator>
  <dc:creator>van der Doef, Thalia F</dc:creator>
  <dc:creator>Horstman, Paul</dc:creator>
  <dc:creator>Huisman, Marc C</dc:creator>
  <dc:creator>Schuit, Robert C</dc:creator>
  <dc:creator>van Lingen, Arthur</dc:creator>
  <dc:creator>Windhorst, Albert D</dc:creator>
  <dc:creator>van Berckel, Bart,NM</dc:creator>
  <dc:creator>Lammerstma, Adriaan A</dc:creator>
  <dc:date>2017-02-09</dc:date>
  <dc:description>The methylguanadine derivative [11C]GMOM has been used successfully to quantify N-methyl-D-aspartate (NMDA) receptor binding in humans. The purpose of the present study was to estimate the [11C]GMOM radiation dose in healthy humans.

Methods: Following [11C]GMOM injection, three female and two male subjects underwent 10 consecutive whole body PET scans in approximately 77 minutes. 7 source organs were defined manually, scaled to a gender specific reference, and residence times were calculated for input into OLINDA/EXM software. Accepted tissue weighting factors (ICRP103) were used to calculate the effective dose.

Results: Absorbed radiation doses in source organs ranged from 7.7 µGy·MBq-1 in the brain to 12.7 µGy·MBq-1 in the spleen. The effective dose (±SD) was 4.5 ± 0.5 µSv·MBq-1

Conclusion: The effective dose of [11C]GMOM is at the lower end of the range seen for other C-11 labelled ligands, allowing for serial PET scanning in a single subject.</dc:description>
  <dc:identifier>https://zenodo.org/record/400829</dc:identifier>
  <dc:identifier>10.2967/jnumed.116.188250</dc:identifier>
  <dc:identifier>oai:zenodo.org:400829</dc:identifier>
  <dc:relation>info:eu-repo/grantAgreement/EC/FP7/278850/</dc:relation>
  <dc:relation>url:https://zenodo.org/communities/ecfunded</dc:relation>
  <dc:relation>url:https://zenodo.org/communities/inmind</dc:relation>
  <dc:rights>info:eu-repo/semantics/closedAccess</dc:rights>
  <dc:source>Journal of Nuclear Medicine 58(8) 1330-1333</dc:source>
  <dc:subject>11C</dc:subject>
  <dc:subject>Dosimetry</dc:subject>
  <dc:subject>NMDA</dc:subject>
  <dc:subject>Neurology</dc:subject>
  <dc:subject>PET</dc:subject>
  <dc:subject>PET/CT</dc:subject>
  <dc:subject>Radiobiology/Dosimetry</dc:subject>
  <dc:title>Human Dosimetry of the NMDA Receptor Ligand [11C]GMOM.</dc:title>
  <dc:type>info:eu-repo/semantics/article</dc:type>
  <dc:type>publication-article</dc:type>
</oai_dc:dc>
11
0
views
downloads
Views 11
Downloads 0
Data volume 0 Bytes
Unique views 11
Unique downloads 0

Share

Cite as